Ekaterina Cleary

Ekaterina Cleary, Ph.D.

Managing Scientist
Data Sciences
Natick
  • CV (English)
  • Contact Card

Dr. Cleary is a data scientist with expertise in visual data analytics. She has 8+ years of experience in life sciences performing epidemiology, statistics and genomics research to provide data-driven recommendations that inform health policy. She specializes in organizing, managing and analyzing health care data sets using rigorous analysis and integration of a broad base of statistical and visualization tools.

Prior to joining Exponent, Dr. Cleary was a Research Associate and Lead Data Analyst at the Center for Integration of Science and Industry, where her research examined the public sector contribution to the science underlying new drug discovery and the public value created from this science. She also held an Adjunct Professor position at Bentley University, where she taught Data Visualization for Business Intelligence at the graduate level.

Dr. Cleary received her Ph.D. in Biomedical Engineering and Biotechnology from the University of Massachusetts Lowell in 2016. Her dissertation focused on statistical modeling of environmental risk factors influencing Alzheimer’s disease progression. She was project lead on designing an interactive map of ultrafine particle pollution in the Chinatown region of Boston, MA. She also holds an M.S. degree in Bioinformatics from Boston University.

CREDENTIALS & PROFESSIONAL HONORS

  • Ph.D., Biomedical Engineering and Biotechnology, University of Massachusetts, Lowell, 2016
  • M.S., Bioinformatics, Boston University, 2009
  • B.S., Biology/Bioinformatics, University of Massachusetts, Lowell, 2007
  • Bentley University Outstanding Scholarly Contribution Award, 2019

LANGUAGES

  • Russian
  • French

Publications

Kiszewski, A. E., Galkina Cleary, E. I., Jackson, M. J., & Ledley, F. D. The role of NIH funding in vaccine readiness; foundational research and funding underlying candidate SARS-CoV-2 vaccines. Vaccine Journal, 2021, in press

Cleary EG, McNamee LM, de Boer S, Holden J, Fitzgerald L, Ledley FD (2021) Comparing long-term value creation after biotech and non-biotech IPOs, 1997–2016. PLoS ONE 16(1): e0243813.

McNamee LM, Cleary EG, Zhang S, Salim U, Ledley FD (2020), Late-Stage Product Development and Approvals by Biotechnology Companies After Initial Public Offering, 1997–2016, Clinical Therapeutics

Cleary, E. G., Jackson, M. J., Folchman-Wagner, Z., & Ledley, F. D. Foundational research and NIH funding enabling emergency use authorization of remdesivir for COVID-19. Medrxiv, 2020

Cleary E.G., Ledley F.D. NIH funding for research underlying new cancer therapies: the importance of spillover effects. Lancet Oncology, 21(3):755-757, 2020

Ledley F.D., McCoy S.S., Vaughan G, Cleary E.G. Profitability of Large Pharmaceutical Companies Compared with Other Large Public Companies. JAMA, 323(9):834–843, 2020

Vaughan D.A., Seidler E.A., Murphy L.A, Cleary E.G., Penzias A., Norwitz E.R., Sakkas D. Double trouble? Clinic-specific risk factors for monozygotic twinning. Fertility and Sterility, 2020

Wong C., Wu H.C., Galkina Cleary E., Patton A.P., Xie A., Koch-Weser S. and Brugge D. Visualizing Air Pollution: Communication of Environmental Health Information in a Chinese Immigrant Community. Journal of Health Communication, 2019

Galkina Cleary, E., Beierlein, J. M., Khanuja, N., McNamee, L. M. and Ledley, F. D. Contribution of NIH funding to new drug approvals 2010-2016. Proceedings of the National Academy of Sciences USA. 2018

Galkina Cleary, E., Cifuentes, M., Grinstein, G., Brugge, D. and Shea, T. B. Association of Low-Level Ozone with Cognitive Decline in Older Adults. Journal of Alzheimer's disease: JAD, 61 (1), 67-78, 2018

E. Galkina, A.P. Patton, HC. Wu, J. Stubblefield, W. Mass, G. Grinstein, S. Koch-Weser, D. Brugge and C. Wong. “Making Air Pollution Visible: A Tool for Promoting Environmental Health Literacy”, J JMIR public health and surveillance, 3 (2), e16, 2017.

K. Maas, E. Galkina, K. Thornton, A, Penzias and D. Sakkas. “No Change in Live Birth Weight of IVF Singleton Deliveries Over an 18-Year Period Despite Significant Clinical and Laboratory Changes”, Hum Reprod., pii: dew173, July 4. 2016.

E.I. Galkina, A. Shin, K.R. Coser, T. Shioda, I.S. Kohane, IS. Seong, V.C. Wheeler, J.F. Gusella, M.E. MacDonald and J-M. Lee. "HD CAGnome: a search tool for huntingtin CAG repeat length-correlated genes," PLoS One, vol. 9, pp. e95556, Apr 21. 2014

JM. Lee, E.I. Galkina, R.M. Levantovsky, E. Fossale, MA. Anderson, T. Gillis, J.S. Mysore, K.R. Coser, T. Shioda, B. Zhang, M. Furia, J. Derry, I.S. Kohane, I.S. Seong, V.C. Wheeler, J.F. Gusella and M.E. MacDonald, "Dominant effects of the Huntington's disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategy," Hum.Mol.Genet., Apr 24. 2013

Presentations

E.I. Galkina and G.G. Grinstein, "Regional Differences in Diagnostic Conversion to Dementia," IEEE’s 18th International Conference on Information Visualization (iV2014), Paris, France, 2014.

E.I. Galkina and G.G. Grinstein, “Challenges of Exploratory Visualization of Gene-Environment Interaction in Alzheimer’s Disease”, IEEE’s 16th International Conference on Information Visualization (iV2012), Montpellier, France, 2012.

Prior Experience

Research Associate, Bentley University, Center for Integration of Science and Industry, 2016 – 2021

Statistical consultant, Boston IVF, 2015 – 2020

Graduate Research Assistant, University of Massachusetts Lowell, 2011 – 2015

Summer Intern, Ecole Normale Supérieure de Paris (INSERM), Institut de Biologie, Paris, France, 2011

Bioinformatics analyst, Massachusetts General Hospital (MGH), 2009 – 2011

Summer Intern, Dana Farber Cancer Institute, 2008

Academic Appointments

Adjunct Professor, Mathematical Sciences, Bentley University, 2018-2019

Professional Affiliations

Society of Children’s Book Writers and Illustrators

Additional Information

Additional Education Training

Tufts CSDD Postgraduate Course in Clinical Pharmacology, Drug Development and Regulation (2017)

Peer Reviewer

Neuroepidemiology

CREDENTIALS & PROFESSIONAL HONORS

  • Ph.D., Biomedical Engineering and Biotechnology, University of Massachusetts, Lowell, 2016
  • M.S., Bioinformatics, Boston University, 2009
  • B.S., Biology/Bioinformatics, University of Massachusetts, Lowell, 2007
  • Bentley University Outstanding Scholarly Contribution Award, 2019

LANGUAGES

  • Russian
  • French